1. Home
  2. NSSC vs PRAX Comparison

NSSC vs PRAX Comparison

Compare NSSC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$46.20

Market Cap

1.4B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$337.18

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
PRAX
Founded
1969
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
9.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
NSSC
PRAX
Price
$46.20
$337.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
15
Target Price
$48.17
$572.13
AVG Volume (30 Days)
545.6K
386.6K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
1.29%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$181,621,000.00
N/A
Revenue This Year
$13.47
N/A
Revenue Next Year
$9.75
$1,840.20
P/E Ratio
$64.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.63
$26.70
52 Week High
$47.61
$354.87

Technical Indicators

Market Signals
Indicator
NSSC
PRAX
Relative Strength Index (RSI) 64.74 59.96
Support Level $41.96 $290.36
Resistance Level $47.61 N/A
Average True Range (ATR) 1.68 18.81
MACD 0.29 -0.01
Stochastic Oscillator 82.80 71.32

Price Performance

Historical Comparison
NSSC
PRAX

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: